If you are visually impaired or blind, you can visit the PDF version by Pressing CONTROL + ALT + 4
<br /> INNOVATIONS<br /> ISSN 2513-8634 Vol 3.1 • January 2019 • europeanmedical-journal.com<br /> INSIDE<br /> Review of<br /> MEDICA 2018<br /> Düsseldorf, Germany<br /> Contents<br /> EDITORIAL BOARD 4<br /> WELCOME 7<br /> FOREWORD 9<br /> 01 CONGRESS REVIEW<br /> Review of MEDICA 2018, held in Düsseldorf, Germany, 12<br /> 12th–15th November 2018<br /> 02 INFOGRAPHIC: THE RISE OF MEDICAL TECHNOLOGY 24<br /> 03 INTERVIEWS WITH EMJ INNOVATIONS EDITORIAL BOARD<br /> Prof Rachel Dunscom<a title="EMJ Innovations 3.1 2019 page 1" href="http://viewer.zmags.com/publication/4a24b269?page=1"> INNOVATIONS ISSN 2513-8634 </a> <a title="EMJ Innovations 3.1 2019 page 2" href="http://viewer.zmags.com/publication/4a24b269?page=2"> Contents EDITORIAL BOARD </a> <a title="EMJ Innovations 3.1 2019 page 3" href="http://viewer.zmags.com/publication/4a24b269?page=3"> “MEDICA is the most prominent event f</a> <a title="EMJ Innovations 3.1 2019 page 4" href="http://viewer.zmags.com/publication/4a24b269?page=4"> Editorial Board Editor-in-Chief Prof Mike Bewick </a> <a title="EMJ Innovations 3.1 2019 page 5" href="http://viewer.zmags.com/publication/4a24b269?page=5"> Aims and Scope The European Medical Journal (EMJ)</a> <a title="EMJ Innovations 3.1 2019 page 6" href="http://viewer.zmags.com/publication/4a24b269?page=6"> EMJ Innov. Chief Executive Officer Spencer Gore S</a> <a title="EMJ Innovations 3.1 2019 page 7" href="http://viewer.zmags.com/publication/4a24b269?page=7"> Welcome Starting 2019 as we mean to go on, I am p</a> <a title="EMJ Innovations 3.1 2019 page 8" href="http://viewer.zmags.com/publication/4a24b269?page=8"> Looking for a new job opportunity? </a> <a title="EMJ Innovations 3.1 2019 page 9" href="http://viewer.zmags.com/publication/4a24b269?page=9"> Foreword Welcome to the latest edition of the EMJ</a> <a title="EMJ Innovations 3.1 2019 page 10" href="http://viewer.zmags.com/publication/4a24b269?page=10"> Available now.</a> <a title="EMJ Innovations 3.1 2019 page 11" href="http://viewer.zmags.com/publication/4a24b269?page=11"> Discover inside: Feature + The Lancet Asthma C</a> <a title="EMJ Innovations 3.1 2019 page 12" href="http://viewer.zmags.com/publication/4a24b269?page=12"> </a> <a title="EMJ Innovations 3.1 2019 page 13" href="http://viewer.zmags.com/publication/4a24b269?page=13"> Congress Review Review of MEDIC</a> <a title="EMJ Innovations 3.1 2019 page 14" href="http://viewer.zmags.com/publication/4a24b269?page=14"> Topics such as big data, artificial intelligence, </a> <a title="EMJ Innovations 3.1 2019 page 15" href="http://viewer.zmags.com/publication/4a24b269?page=15"> Smart Glasses Set to Take the Lead in Eye Therapy</a> <a title="EMJ Innovations 3.1 2019 page 16" href="http://viewer.zmags.com/publication/4a24b269?page=16"> MEDICA App Competition 2018 THEY SAY seven is a m</a> <a title="EMJ Innovations 3.1 2019 page 17" href="http://viewer.zmags.com/publication/4a24b269?page=17"> onset, seeking to identify issues faced by patien</a> <a title="EMJ Innovations 3.1 2019 page 18" href="http://viewer.zmags.com/publication/4a24b269?page=18"> A New HIV Test on the Block THE EUROPEAN Centre f</a> <a title="EMJ Innovations 3.1 2019 page 19" href="http://viewer.zmags.com/publication/4a24b269?page=19"> Increasing Antibiotic Efficacy After Joint Implan</a> <a title="EMJ Innovations 3.1 2019 page 20" href="http://viewer.zmags.com/publication/4a24b269?page=20"> One of the barriers athletes, especially enduranc</a> <a title="EMJ Innovations 3.1 2019 page 21" href="http://viewer.zmags.com/publication/4a24b269?page=21"> There are two significant problems with the </a> <a title="EMJ Innovations 3.1 2019 page 22" href="http://viewer.zmags.com/publication/4a24b269?page=22"> neurostimulation and robotics was conducted, as </a> <a title="EMJ Innovations 3.1 2019 page 23" href="http://viewer.zmags.com/publication/4a24b269?page=23"> The fast treatment and monitoring of chronic cond</a> <a title="EMJ Innovations 3.1 2019 page 24" href="http://viewer.zmags.com/publication/4a24b269?page=24"> The Rise of Medical Technology The Location of</a> <a title="EMJ Innovations 3.1 2019 page 25" href="http://viewer.zmags.com/publication/4a24b269?page=25"> hnology Companies by The Sectors</a> <a title="EMJ Innovations 3.1 2019 page 26" href="http://viewer.zmags.com/publication/4a24b269?page=26"> Referenc 1. Globa tor An Select Accel g</a> <a title="EMJ Innovations 3.1 2019 page 27" href="http://viewer.zmags.com/publication/4a24b269?page=27"> Interviews Take the opportunity to learn more a</a> <a title="EMJ Innovations 3.1 2019 page 28" href="http://viewer.zmags.com/publication/4a24b269?page=28"> The programme provides practical, hands-on ex</a> <a title="EMJ Innovations 3.1 2019 page 29" href="http://viewer.zmags.com/publication/4a24b269?page=29"> patient monitoring apps, and automated sc</a> <a title="EMJ Innovations 3.1 2019 page 30" href="http://viewer.zmags.com/publication/4a24b269?page=30"> on the most complex work, which gives them the mo</a> <a title="EMJ Innovations 3.1 2019 page 31" href="http://viewer.zmags.com/publication/4a24b269?page=31"> I think the top priority in healthcare is how to </a> <a title="EMJ Innovations 3.1 2019 page 32" href="http://viewer.zmags.com/publication/4a24b269?page=32"> living in the same place. Ensuring that th</a> <a title="EMJ Innovations 3.1 2019 page 33" href="http://viewer.zmags.com/publication/4a24b269?page=33"> a public health position in relation to eHealth. </a> <a title="EMJ Innovations 3.1 2019 page 34" href="http://viewer.zmags.com/publication/4a24b269?page=34"> that allow for informed consent (including the ab</a> <a title="EMJ Innovations 3.1 2019 page 35" href="http://viewer.zmags.com/publication/4a24b269?page=35"> AI and machine learning are incredibly interestin</a> <a title="EMJ Innovations 3.1 2019 page 36" href="http://viewer.zmags.com/publication/4a24b269?page=36"> Four-Dimensional Bioprinting for Regenerative </a> <a title="EMJ Innovations 3.1 2019 page 37" href="http://viewer.zmags.com/publication/4a24b269?page=37"> proper assessment of the constructs. The effectiv</a> <a title="EMJ Innovations 3.1 2019 page 38" href="http://viewer.zmags.com/publication/4a24b269?page=38"> laboratorial constructs and the native human</a> <a title="EMJ Innovations 3.1 2019 page 39" href="http://viewer.zmags.com/publication/4a24b269?page=39"> being created with single and multishap</a> <a title="EMJ Innovations 3.1 2019 page 40" href="http://viewer.zmags.com/publication/4a24b269?page=40"> Box 1: Regenerative engineering may closely repli</a> <a title="EMJ Innovations 3.1 2019 page 41" href="http://viewer.zmags.com/publication/4a24b269?page=41"> to a collapse or expansion of the material</a> <a title="EMJ Innovations 3.1 2019 page 42" href="http://viewer.zmags.com/publication/4a24b269?page=42"> References 1. Murphy SV, Atala A. 3D bioprin</a> <a title="EMJ Innovations 3.1 2019 page 43" href="http://viewer.zmags.com/publication/4a24b269?page=43"> memory polymers to deliver time- 52. con</a> <a title="EMJ Innovations 3.1 2019 page 44" href="http://viewer.zmags.com/publication/4a24b269?page=44"> An Overview of Atopic Dermatitis with a Fo</a> <a title="EMJ Innovations 3.1 2019 page 45" href="http://viewer.zmags.com/publication/4a24b269?page=45"> Over the years, other names have been</a> <a title="EMJ Innovations 3.1 2019 page 46" href="http://viewer.zmags.com/publication/4a24b269?page=46"> Host Environment (defence) 1. Gene 2. Hygiene hyp</a> <a title="EMJ Innovations 3.1 2019 page 47" href="http://viewer.zmags.com/publication/4a24b269?page=47"> in preschool children with AD compared to c</a> <a title="EMJ Innovations 3.1 2019 page 48" href="http://viewer.zmags.com/publication/4a24b269?page=48"> Primary and Secondary Prevention The proposal of </a> <a title="EMJ Innovations 3.1 2019 page 49" href="http://viewer.zmags.com/publication/4a24b269?page=49"> Systemic Immunosuppressant Treatment Since oral c</a> <a title="EMJ Innovations 3.1 2019 page 50" href="http://viewer.zmags.com/publication/4a24b269?page=50"> Inflammation Nanoparticles Hair shaft Infl</a> <a title="EMJ Innovations 3.1 2019 page 51" href="http://viewer.zmags.com/publication/4a24b269?page=51"> Ballerup, Denmark). The treatment efficacy on cli</a> <a title="EMJ Innovations 3.1 2019 page 52" href="http://viewer.zmags.com/publication/4a24b269?page=52"> there was higher skin permeation and retention of</a> <a title="EMJ Innovations 3.1 2019 page 53" href="http://viewer.zmags.com/publication/4a24b269?page=53"> 2011;56(5):471-5. 12. Alsaad KO, Ghazarian D. M</a> <a title="EMJ Innovations 3.1 2019 page 54" href="http://viewer.zmags.com/publication/4a24b269?page=54"> skin-assessment by intradermal microdialysis and </a> <a title="EMJ Innovations 3.1 2019 page 55" href="http://viewer.zmags.com/publication/4a24b269?page=55"> Interact with us on social med</a> <a title="EMJ Innovations 3.1 2019 page 56" href="http://viewer.zmags.com/publication/4a24b269?page=56"> The Need for Greater Reporting of Medical Dev</a> <a title="EMJ Innovations 3.1 2019 page 57" href="http://viewer.zmags.com/publication/4a24b269?page=57"> Administration (FDA) estimates the reporting </a> <a title="EMJ Innovations 3.1 2019 page 58" href="http://viewer.zmags.com/publication/4a24b269?page=58"> under-reporting of adverse events. In Australia, </a> <a title="EMJ Innovations 3.1 2019 page 59" href="http://viewer.zmags.com/publication/4a24b269?page=59"> 25 Number of device incident reports 20 15 </a> <a title="EMJ Innovations 3.1 2019 page 60" href="http://viewer.zmags.com/publication/4a24b269?page=60"> manufacturer’s quality management systems with</a> <a title="EMJ Innovations 3.1 2019 page 61" href="http://viewer.zmags.com/publication/4a24b269?page=61"> Case Study 3: Breast Implant-Associated Anaplasti</a> <a title="EMJ Innovations 3.1 2019 page 62" href="http://viewer.zmags.com/publication/4a24b269?page=62"> generated for several years. Mandatory reporting </a> <a title="EMJ Innovations 3.1 2019 page 63" href="http://viewer.zmags.com/publication/4a24b269?page=63"> had transvaginal mesh implants 19. a</a> <a title="EMJ Innovations 3.1 2019 page 64" href="http://viewer.zmags.com/publication/4a24b269?page=64"> Anti-Calcitonin Gene-Related Peptide </a> <a title="EMJ Innovations 3.1 2019 page 65" href="http://viewer.zmags.com/publication/4a24b269?page=65"> treatment compliance and adherence (up to 68</a> <a title="EMJ Innovations 3.1 2019 page 66" href="http://viewer.zmags.com/publication/4a24b269?page=66"> No deaths or serious AE (SAE) were reported in th</a> <a title="EMJ Innovations 3.1 2019 page 67" href="http://viewer.zmags.com/publication/4a24b269?page=67"> In Phase II clinical trials of both CM and high f</a> <a title="EMJ Innovations 3.1 2019 page 68" href="http://viewer.zmags.com/publication/4a24b269?page=68"> AE were similar to placebo. Other frequently repo</a> <a title="EMJ Innovations 3.1 2019 page 69" href="http://viewer.zmags.com/publication/4a24b269?page=69"> group (n=25) and 8.9% (n=18; 120 mg group) and 1</a> <a title="EMJ Innovations 3.1 2019 page 70" href="http://viewer.zmags.com/publication/4a24b269?page=70"> CONCLUSION Monoclonal antibodies against CGRP </a> <a title="EMJ Innovations 3.1 2019 page 71" href="http://viewer.zmags.com/publication/4a24b269?page=71"> antagonizes human alpha-calcitonin 39. gene</a> <a title="EMJ Innovations 3.1 2019 page 72" href="http://viewer.zmags.com/publication/4a24b269?page=72"> controlled study to evaluate the </a> <a title="EMJ Innovations 3.1 2019 page 73" href="http://viewer.zmags.com/publication/4a24b269?page=73"> Association of a Biomarker-Based Frailty Index w</a> <a title="EMJ Innovations 3.1 2019 page 74" href="http://viewer.zmags.com/publication/4a24b269?page=74"> cumulative burden of ageing-related health de</a> <a title="EMJ Innovations 3.1 2019 page 75" href="http://viewer.zmags.com/publication/4a24b269?page=75"> Table 1: Computation of frailty index. Deficits </a> <a title="EMJ Innovations 3.1 2019 page 76" href="http://viewer.zmags.com/publication/4a24b269?page=76"> Since not all the items comprising FP were</a> <a title="EMJ Innovations 3.1 2019 page 77" href="http://viewer.zmags.com/publication/4a24b269?page=77"> Statistical Analysis To examine the association o</a> <a title="EMJ Innovations 3.1 2019 page 78" href="http://viewer.zmags.com/publication/4a24b269?page=78"> This sample was 48% female and the breakdown of r</a> <a title="EMJ Innovations 3.1 2019 page 79" href="http://viewer.zmags.com/publication/4a24b269?page=79"> As detailed in the methods section, secondary ana</a> <a title="EMJ Innovations 3.1 2019 page 80" href="http://viewer.zmags.com/publication/4a24b269?page=80"> tobacco smoking on telomere length.38,39 The </a> <a title="EMJ Innovations 3.1 2019 page 81" href="http://viewer.zmags.com/publication/4a24b269?page=81"> on laboratory deficits in community- 25. dwe</a> <a title="EMJ Innovations 3.1 2019 page 82" href="http://viewer.zmags.com/publication/4a24b269?page=82"> Breaking Down Silos in Asthma Research: The C</a> <a title="EMJ Innovations 3.1 2019 page 83" href="http://viewer.zmags.com/publication/4a24b269?page=83"> the identification and development of novel t</a> <a title="EMJ Innovations 3.1 2019 page 84" href="http://viewer.zmags.com/publication/4a24b269?page=84"> have been applied in asthma research. For e</a> <a title="EMJ Innovations 3.1 2019 page 85" href="http://viewer.zmags.com/publication/4a24b269?page=85"> Benefits of cross-disciplinary collaborations and </a> <a title="EMJ Innovations 3.1 2019 page 86" href="http://viewer.zmags.com/publication/4a24b269?page=86"> obvious. The statistical literacy of the clinical</a> <a title="EMJ Innovations 3.1 2019 page 87" href="http://viewer.zmags.com/publication/4a24b269?page=87"> facilities anticipate asthma-related visits a</a> <a title="EMJ Innovations 3.1 2019 page 88" href="http://viewer.zmags.com/publication/4a24b269?page=88"> The use of modern techniques, such as machine lea</a> <a title="EMJ Innovations 3.1 2019 page 89" href="http://viewer.zmags.com/publication/4a24b269?page=89"> Table 1 continued. Data source Strengths </a> <a title="EMJ Innovations 3.1 2019 page 90" href="http://viewer.zmags.com/publication/4a24b269?page=90"> The prediction of asthma in preschool children wi</a> <a title="EMJ Innovations 3.1 2019 page 91" href="http://viewer.zmags.com/publication/4a24b269?page=91"> of parentally reported and physician- 32. co</a> <a title="EMJ Innovations 3.1 2019 page 92" href="http://viewer.zmags.com/publication/4a24b269?page=92"> Thorax. 2017;73(4):313-20. 64. Turner SW et al. </a> <a title="EMJ Innovations 3.1 2019 page 93" href="http://viewer.zmags.com/publication/4a24b269?page=93"> We want you to write for the </a> <a title="EMJ Innovations 3.1 2019 page 94" href="http://viewer.zmags.com/publication/4a24b269?page=94"> What's New Targeted Brain Stimulation Could Reli</a> <a title="EMJ Innovations 3.1 2019 page 95" href="http://viewer.zmags.com/publication/4a24b269?page=95"> Xenon-Based Contrast Media to Revolutionise MRI D</a> <a title="EMJ Innovations 3.1 2019 page 96" href="http://viewer.zmags.com/publication/4a24b269?page=96"> What's New Ground-Breaking Developmen</a> <a title="EMJ Innovations 3.1 2019 page 97" href="http://viewer.zmags.com/publication/4a24b269?page=97"> The Next Step in Pregnancy Research: Lab-Grown Pl</a> <a title="EMJ Innovations 3.1 2019 page 98" href="http://viewer.zmags.com/publication/4a24b269?page=98"> Events 18TH–19TH MARCH 2019 6TH APRIL 2019 </a> <a title="EMJ Innovations 3.1 2019 page 99" href="http://viewer.zmags.com/publication/4a24b269?page=99"> 15TH–16TH MAY 2019 22ND–23RD JULY 2019 </a> <a title="EMJ Innovations 3.1 2019 page 100" href="http://viewer.zmags.com/publication/4a24b269?page=100"> Never miss an update again. J</a>